Details, Fiction and who makes copyright semaglutide
In March 2025, the company declared new plans for just a immediate-to-client featuring of its Wegovy weight loss drug. The company established a different pharmacy, called NovoCare, which would demand customers $499 a month for access to the drug, less than 50 % the expense of the drug by means of other pharmaceutical distribution networks.[53]Nota